{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:49:34Z","timestamp":1789764574384,"version":"4.0.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","ajicjournal.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ajic.2023.09.007","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T01:02:55Z","timestamp":1698886975000},"page":"280-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of doxycycline on Clostridioides difficile infection in patients hospitalized with community-acquired pneumonia"],"prefix":"10.1016","volume":"52","author":[{"given":"Ashley L.","family":"O\u2019Leary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany A.","family":"Wattengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari A.","family":"Mergenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2023.09.007_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-023-08096-0","article-title":"The burden of CDI in the United States: a multifactorial challenge","volume":"23","author":"Feuerstadt","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajic.2023.09.007_bib2","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.jamda.2022.01.075","article-title":"Mortality, health care use, and costs of Clostridioides difficile infections in older adults","volume":"23","author":"Feuerstadt","year":"2022","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.ajic.2023.09.007_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2023.09.007_bib4","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.cmi.2016.08.017","article-title":"Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study","volume":"22","author":"Gergely Szabo","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ajic.2023.09.007_bib5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/AAC.00839-10","article-title":"Tigecycline exhibits inhibitory activity against Clostridium difficile in the colon of mice and does not promote growth or toxin production","volume":"55","author":"Jump","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2023.09.007_bib6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/cid\/cis457","article-title":"Does doxycycline protect against development of Clostridium difficile infection?","volume":"55","author":"Doernberg","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2023.09.007_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajic.2023.09.007_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1086\/524320","article-title":"Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients","volume":"29","author":"Baxter","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2023.09.007_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/infdis\/169.1.127","article-title":"Epidemiology of community-acquired Clostridium difficile-associated diarrhea","volume":"169","author":"Hirschhorn","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajic.2023.09.007_bib10","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/jac\/dkg191","article-title":"Legionnaires' disease: a rational approach to therapy","volume":"51","author":"Roig","year":"2003","journal-title":"J Antimicrob Chemother"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655323006284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655323006284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T20:40:21Z","timestamp":1725309621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655323006284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0196655323006284"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2023.09.007","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of doxycycline on Clostridioides difficile infection in patients hospitalized with community-acquired pneumonia","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2023.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}